{"success":true,"data":{"pressRelease":{"id":"129559","rtpr_id":"nPn8YjwlTa","ticker":"PODD","exchange":"NASDAQ","all_tickers":["PODD"],"title":"SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD","author":"PR Newswire","published_at":"2026-08-27T14:07:00.426Z","article_body":"SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD\n\nPR Newswire\n\nNEW YORK, Aug. 27, 2026\n\nNotice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD:\nInstitutional Portfolios Face Significant Exposure Following Two Omnipod\nMedical Device Corrections and Over $90 Per Share Decline from Pre-Disclosure\nLevels\n\nNEW YORK, Aug. 27, 2026 /PRNewswire/ -- Institutional investors holding\npositions in Insulet Corporation (NASDAQ: PODD) during the period from\nFebruary 21, 2025 through May 26, 2026 may wish to evaluate lead plaintiff\nopportunities in a pending securities class action. Click here to see if you\nmay be eligible to recover.\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760312-11&h=1533873024&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Finsulet-corporation-class-action-lawsuit-podd%3Fprid%3D192480%26wire%3D4&a=Click+here+to+see+if+you+may+be+eligible+to+recover.)\n You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com\n(mailto:jlevi@SueWallSt.com)  or (888) SueWallSt.\n\nInsulet shares declined from approximately $236 to $146.01 per share across\ntwo corrective disclosures revealing systemic manufacturing defects at the\nCompany's Acton, Massachusetts facility. The window to apply for lead\nplaintiff closes on August 31, 2026.\n\nNotice to Institutional Holders\n\nFiduciaries overseeing portfolios that included PODD securities during the\nClass Period should assess whether their funds purchased shares at prices that\nwere allegedly artificially inflated by undisclosed manufacturing control\nfailures. The magnitude of the stock-price declines, combined with allegations\nthat management concealed material manufacturing deficiencies and\nquality-control issues affecting its Omnipod products, raises questions that\nfiduciaries should evaluate promptly.\n\nFiduciary Obligations and Recovery Options\n\nInstitutional holders should consider the following:\n\n * The stock declined approximately $24 per share across the two immediate\ncorrective disclosures which revealed manufacturing deficiencies that\ncontradicted management's public statements regarding manufacturing quality,\nproduct safety, and quality-control processes.\n * The complaint alleges that Insulet failed to disclose manufacturing defects\nand quality-control deficiencies that ultimately resulted in two Medical\nDevice Corrections.\n * Institutions that purchased shares at artificially inflated prices during the\nClass Period may recover losses without out-of-pocket costs through the class\naction mechanism\n * Lead plaintiff appointment provides direct oversight of case strategy,\nsettlement negotiations, and counsel selection\n * ERISA-governed plans holding PODD may have independent obligations to evaluate\nrecovery options on behalf of plan participants\nContact us to learn more about institutional recovery options\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760312-11&h=2541390329&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Finsulet-corporation-class-action-lawsuit-podd%3Fprid%3D192480%26wire%3D4&a=Contact+us+to+learn+more+about+institutional+recovery+options)\n or call (888) SueWallSt.\n\n\"Institutional investors play a critical role in securities class actions.\nFunds with significant PODD losses during the Class Period are well-positioned\nto serve as lead plaintiff, providing oversight that benefits the entire class\nwhile fulfilling fiduciary obligations to their own beneficiaries.\" —\nJoseph E. Levi, Esq.\n\nTo be considered for lead plaintiff, investors must file by August 31, 2026.\n\nWHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi &\nKorsinsky LLP has established itself as a nationally-recognized securities\nlitigation firm that has secured hundreds of millions of dollars for aggrieved\nshareholders and built a track record of winning high-stakes cases. The firm\nhas extensive expertise representing investors in complex securities\nlitigation and a team of over 70 employees to serve our clients. For seven\nyears in a row, Levi & Korsinsky has ranked in ISS Securities Class Action\nServices' Top 50 Report as one of the top securities litigation firms in the\nUnited States.\n\nFrequently Asked Questions About the PODD Lawsuit\n\nQ: What is the PODD class action lawsuit about? A: A securities class action\nhas been filed against Insulet Corporation (NASDAQ: PODD) alleging materially\nfalse and misleading statements between February 21, 2025 and May 26, 2026.\nShares fell approximately 38% from their pre-disclosure price after the\ncompany disclosed two Medical Device Corrections systemic in its Omnipod\ninsulin delivery devices, causing significant losses for shareholders.\n\nQ: Who is eligible to join the PODD investor lawsuit? A: Investors who\npurchased PODD stock or securities between February 21, 2025 and May 26, 2026\nand suffered financial losses may be eligible. Eligibility is based on\npurchase date and documented losses, not on whether you still hold the shares.\n\nQ: What is a lead plaintiff and why does it matter? A: A lead plaintiff is\nthe investor appointed by the court to represent the entire class. Lead\nplaintiffs are typically investors with the largest documented losses. Being\nappointed does not increase individual recovery but gives direct oversight of\nhow the case is run.\n\nQ: What does it cost me to participate? A: Nothing. Securities class actions\nare handled on a pure contingency basis. No upfront fees, no retainer, no\nout-of-pocket costs.\n\nQ: What if I already sold my PODD shares — can I still recover losses? A:\nYes. Eligibility is based on when you purchased, not whether you still hold\nthem. Investors who bought during the class period and sold at a loss may\nstill participate.\n\nQ: What documents do I need to make a claim? A: Brokerage statements or trade\nconfirmations showing purchase dates, share quantities, prices paid, and any\nsubsequent sale dates and prices.\n\nQ: How long will the lawsuit take to resolve? A: Securities class actions\ntypically take two to four years from initial filing to resolution.\n\nCONTACT:\nLevi & Korsinsky, LLP\nJoseph E. Levi, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@SueWallSt.com (mailto:jlevi@SueWallSt.com)\nTel: (888) SueWallSt\nFax: (212) 363-7171\n\nAttorney Advertising. Prior results do not guarantee similar outcomes.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-august-31-2026-in-insulet-corporation-lawsuit---podd-302861346.html\n(https://www.prnewswire.com/news-releases/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-august-31-2026-in-insulet-corporation-lawsuit---podd-302861346.html)\n\nSOURCE SueWallSt.com\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1812443/suewallst-logo-1-Logo.jpg?id=OA2913953\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn8YjwlTa","title":"SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD","author":"PR Newswire","ticker":"PODD","created":"2026-08-27T14:07:00.426Z","tickers":["PODD"],"exchange":"NASDAQ","article_body":"SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD\n\nPR Newswire\n\nNEW YORK, Aug. 27, 2026\n\nNotice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD:\nInstitutional Portfolios Face Significant Exposure Following Two Omnipod\nMedical Device Corrections and Over $90 Per Share Decline from Pre-Disclosure\nLevels\n\nNEW YORK, Aug. 27, 2026 /PRNewswire/ -- Institutional investors holding\npositions in Insulet Corporation (NASDAQ: PODD) during the period from\nFebruary 21, 2025 through May 26, 2026 may wish to evaluate lead plaintiff\nopportunities in a pending securities class action. Click here to see if you\nmay be eligible to recover.\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760312-11&h=1533873024&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Finsulet-corporation-class-action-lawsuit-podd%3Fprid%3D192480%26wire%3D4&a=Click+here+to+see+if+you+may+be+eligible+to+recover.)\n You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com\n(mailto:jlevi@SueWallSt.com)  or (888) SueWallSt.\n\nInsulet shares declined from approximately $236 to $146.01 per share across\ntwo corrective disclosures revealing systemic manufacturing defects at the\nCompany's Acton, Massachusetts facility. The window to apply for lead\nplaintiff closes on August 31, 2026.\n\nNotice to Institutional Holders\n\nFiduciaries overseeing portfolios that included PODD securities during the\nClass Period should assess whether their funds purchased shares at prices that\nwere allegedly artificially inflated by undisclosed manufacturing control\nfailures. The magnitude of the stock-price declines, combined with allegations\nthat management concealed material manufacturing deficiencies and\nquality-control issues affecting its Omnipod products, raises questions that\nfiduciaries should evaluate promptly.\n\nFiduciary Obligations and Recovery Options\n\nInstitutional holders should consider the following:\n\n * The stock declined approximately $24 per share across the two immediate\ncorrective disclosures which revealed manufacturing deficiencies that\ncontradicted management's public statements regarding manufacturing quality,\nproduct safety, and quality-control processes.\n * The complaint alleges that Insulet failed to disclose manufacturing defects\nand quality-control deficiencies that ultimately resulted in two Medical\nDevice Corrections.\n * Institutions that purchased shares at artificially inflated prices during the\nClass Period may recover losses without out-of-pocket costs through the class\naction mechanism\n * Lead plaintiff appointment provides direct oversight of case strategy,\nsettlement negotiations, and counsel selection\n * ERISA-governed plans holding PODD may have independent obligations to evaluate\nrecovery options on behalf of plan participants\nContact us to learn more about institutional recovery options\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760312-11&h=2541390329&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Finsulet-corporation-class-action-lawsuit-podd%3Fprid%3D192480%26wire%3D4&a=Contact+us+to+learn+more+about+institutional+recovery+options)\n or call (888) SueWallSt.\n\n\"Institutional investors play a critical role in securities class actions.\nFunds with significant PODD losses during the Class Period are well-positioned\nto serve as lead plaintiff, providing oversight that benefits the entire class\nwhile fulfilling fiduciary obligations to their own beneficiaries.\" —\nJoseph E. Levi, Esq.\n\nTo be considered for lead plaintiff, investors must file by August 31, 2026.\n\nWHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi &\nKorsinsky LLP has established itself as a nationally-recognized securities\nlitigation firm that has secured hundreds of millions of dollars for aggrieved\nshareholders and built a track record of winning high-stakes cases. The firm\nhas extensive expertise representing investors in complex securities\nlitigation and a team of over 70 employees to serve our clients. For seven\nyears in a row, Levi & Korsinsky has ranked in ISS Securities Class Action\nServices' Top 50 Report as one of the top securities litigation firms in the\nUnited States.\n\nFrequently Asked Questions About the PODD Lawsuit\n\nQ: What is the PODD class action lawsuit about? A: A securities class action\nhas been filed against Insulet Corporation (NASDAQ: PODD) alleging materially\nfalse and misleading statements between February 21, 2025 and May 26, 2026.\nShares fell approximately 38% from their pre-disclosure price after the\ncompany disclosed two Medical Device Corrections systemic in its Omnipod\ninsulin delivery devices, causing significant losses for shareholders.\n\nQ: Who is eligible to join the PODD investor lawsuit? A: Investors who\npurchased PODD stock or securities between February 21, 2025 and May 26, 2026\nand suffered financial losses may be eligible. Eligibility is based on\npurchase date and documented losses, not on whether you still hold the shares.\n\nQ: What is a lead plaintiff and why does it matter? A: A lead plaintiff is\nthe investor appointed by the court to represent the entire class. Lead\nplaintiffs are typically investors with the largest documented losses. Being\nappointed does not increase individual recovery but gives direct oversight of\nhow the case is run.\n\nQ: What does it cost me to participate? A: Nothing. Securities class actions\nare handled on a pure contingency basis. No upfront fees, no retainer, no\nout-of-pocket costs.\n\nQ: What if I already sold my PODD shares — can I still recover losses? A:\nYes. Eligibility is based on when you purchased, not whether you still hold\nthem. Investors who bought during the class period and sold at a loss may\nstill participate.\n\nQ: What documents do I need to make a claim? A: Brokerage statements or trade\nconfirmations showing purchase dates, share quantities, prices paid, and any\nsubsequent sale dates and prices.\n\nQ: How long will the lawsuit take to resolve? A: Securities class actions\ntypically take two to four years from initial filing to resolution.\n\nCONTACT:\nLevi & Korsinsky, LLP\nJoseph E. Levi, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@SueWallSt.com (mailto:jlevi@SueWallSt.com)\nTel: (888) SueWallSt\nFax: (212) 363-7171\n\nAttorney Advertising. Prior results do not guarantee similar outcomes.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-august-31-2026-in-insulet-corporation-lawsuit---podd-302861346.html\n(https://www.prnewswire.com/news-releases/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-august-31-2026-in-insulet-corporation-lawsuit---podd-302861346.html)\n\nSOURCE SueWallSt.com\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1812443/suewallst-logo-1-Logo.jpg?id=OA2913953\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-27T14:07:00.489933225Z","server_sent_at_ms":1787839620489},"received_at":"2026-08-27T14:07:00.540Z","source_url":"https://www.prnewswire.com/news-releases/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-august-31-2026-in-insulet-corporation-lawsuit---podd-302861346.html"},"analysis":{"id":"118472","press_release_id":"129559","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"SueWallSt, powered by Levi & Korsinsky LLP, issued a reminder of the August 31, 2026 lead plaintiff deadline for a class action lawsuit involving Insulet Corporation (NASDAQ: PODD).\n\nThe lawsuit alleges that the company failed to disclose manufacturing defects and quality-control deficiencies at its Acton, Massachusetts facility related to its Omnipod products, which purportedly caused significant stock price declines.\n\nThis is a plaintiff law-firm solicitation encouraging institutional investors to seek lead plaintiff status and is not a disclosure from the company itself.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"Institutional investors play a critical role in securities class actions.","namedEntities":{"people":[{"name":"Joseph E. Levi, Esq.","role":"Attorney at SueWallSt / Levi & Korsinsky LLP"}],"products":["Omnipod insulin delivery devices"],"companies":[{"name":"Insulet Corporation","ticker":"PODD"},{"name":"SueWallSt","relationship":"plaintiff law firm"},{"name":"Levi & Korsinsky LLP","relationship":"plaintiff law firm"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Levi & Korsinsky LLP (SueWallSt). No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"PODD"},"globalImportance":15,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"SueWallSt, powered by Levi & Korsinsky LLP, issued a reminder of the August 31, 2026 lead plaintiff deadline for a class action lawsuit involving Insulet Corporation (NASDAQ: PODD).\n\nThe lawsuit alleges that the company failed to disclose manufacturing defects and quality-control deficiencies at its Acton, Massachusetts facility related to its Omnipod products, which purportedly caused significant stock price declines.\n\nThis is a plaintiff law-firm solicitation encouraging institutional investors to seek lead plaintiff status and is not a disclosure from the company itself.","key_figures":{},"named_entities":{"people":[{"name":"Joseph E. Levi, Esq.","role":"Attorney at SueWallSt / Levi & Korsinsky LLP"}],"products":["Omnipod insulin delivery devices"],"companies":[{"name":"Insulet Corporation","ticker":"PODD"},{"name":"SueWallSt","relationship":"plaintiff law firm"},{"name":"Levi & Korsinsky LLP","relationship":"plaintiff law firm"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-27T15:55:40.364Z","global_importance":15,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":156150,"modelName":"glm-4.7"}}